These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32058266)

  • 1. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease.
    Jones JD; Rahmani E; Garcia E; Jacobs JP
    Parkinsonism Relat Disord; 2020 Mar; 72():7-12. PubMed ID: 32058266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
    Jones JD; Burroughs M; Apodaca M; Bunch J
    Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease.
    Cholerton B; Johnson CO; Fish B; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Hu SC; Mata IF; Leverenz JB; Poston KL; Montine TJ; Zabetian CP; Edwards KL
    Parkinsonism Relat Disord; 2018 May; 50():29-36. PubMed ID: 29478836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.
    Jones JD; Kurniadi NE; Kuhn TP; Szymkowicz SM; Bunch J; Rahmani E
    Neuropsychology; 2019 Nov; 33(8):1111-1120. PubMed ID: 31343240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.
    Leta V; Urso D; Batzu L; Weintraub D; Titova N; Aarsland D; Martinez-Martin P; Borghammer P; van Wamelen DJ; Yousaf T; Rizos A; Rodriguez-Blazquez C; Chung-Faye G; Chaudhuri KR
    J Parkinsons Dis; 2021; 11(3):1209-1219. PubMed ID: 33843697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.
    Fengler S; Roeske S; Heber I; Reetz K; Schulz JB; Riedel O; Wittchen HU; Storch A; Linse K; Baudrexel S; Hilker R; Mollenhauer B; Witt K; Schmidt N; Balzer-Geldsetzer M; Dams J; Dodel R; Gräber S; Pilotto A; Petrelli A; Fünkele S; Kassubek J; Kalbe E
    Psychol Med; 2016 Aug; 46(11):2275-86. PubMed ID: 27193073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort.
    Chen X; He C; Ma J; Yang R; Qi Q; Gao Z; Du T; Zhang P; Li Y; Cai M; Zhang Y
    CNS Neurosci Ther; 2024 Aug; 30(8):e14918. PubMed ID: 39129413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort.
    Jones JD; Kuhn TP; Szymkowicz SM
    Parkinsonism Relat Disord; 2018 Feb; 47():3-7. PubMed ID: 29233608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
    Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
    Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson's disease.
    Jones JD; Dominguez B; Bunch J; Uribe C; Valenzuela Y; Jacobs JP
    Clin Park Relat Disord; 2021; 5():100104. PubMed ID: 34430845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
    Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
    J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postural instability and gait are associated with severity and prognosis of Parkinson disease.
    van der Heeden JF; Marinus J; Martinez-Martin P; Rodriguez-Blazquez C; Geraedts VJ; van Hilten JJ
    Neurology; 2016 Jun; 86(24):2243-50. PubMed ID: 27178702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.
    Chung J; Ushakova A; Doitsidou M; Tzoulis C; Tysnes OB; Dalen I; Pedersen KF; Alves G; Maple-Grødem J
    Neurosci Lett; 2021 Nov; 764():136243. PubMed ID: 34509566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study.
    Stewart CB; Ledingham D; Foster VK; Anderson KN; Sathyanarayana S; Galley D; Pavese N; Pasquini J
    Front Neurol; 2023; 14():1155669. PubMed ID: 37122303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease progression in Parkinson's disease patients with mild cognitive impairment: 5-year longitudinal study from the early Parkinson's disease longitudinal Singapore (PALS) cohort.
    Deng X; Saffari SE; Xiao B; Ng SYE; Chia N; Choi X; Heng DL; Xu Z; Tay KY; Au WL; Tan EK; Tan LC
    Aging (Albany NY); 2024 Aug; 16(15):11491-11500. PubMed ID: 39137312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Cognitive Changes in De Novo Parkinson's Disease.
    Bayram E; Banks SJ; Shan G; Kaplan N; Caldwell JZK
    J Int Neuropsychol Soc; 2020 Feb; 26(2):241-249. PubMed ID: 31822306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild Cognitive Impairment in Parkinson's Disease-What Is It?
    Weil RS; Costantini AA; Schrag AE
    Curr Neurol Neurosci Rep; 2018 Mar; 18(4):17. PubMed ID: 29525906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.